Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henriette Didriksen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2019
ReplyAnna-Maria Hoffmann-Vold, Henriette Didriksen, Øyvind Molberg
Expert Review of Clinical Immunology|December 21, 2019
The potential of fecal microbiota transplantation in systemic sclerosisAnna-Maria Hoffmann-Vold, Håvard Fretheim, Henriette Didriksen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisHenriette Didriksen, Øyvind Molberg, Håvard Fretheim, et al.
Rheumatology (Oxford, England)|January 23, 2023
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosisNoemi Strahm, Henriette Didriksen, Håvard Fretheim, et al.
Scientific Reports|March 19, 2022
Serum markers of cardiac complications in a systemic sclerosis cohortAnders H Tennøe, Klaus Murbræch, Henriette Didriksen, et al.
Frontiers in Immunology|October 10, 2022
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertensionHenriette Didriksen, Øyvind Molberg, Adi Mehta, et al.
BMJ Open|June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trialAnna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
Plos One|May 22, 2020
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trialHåvard Fretheim, Brian K Chung, Henriette Didriksen, et al.
The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2019
ReplyAnna-Maria Hoffmann-Vold, Henriette Didriksen, Øyvind Molberg
Expert Review of Clinical Immunology|December 21, 2019
The potential of fecal microbiota transplantation in systemic sclerosisAnna-Maria Hoffmann-Vold, Håvard Fretheim, Henriette Didriksen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisHenriette Didriksen, Øyvind Molberg, Håvard Fretheim, et al.
Rheumatology (Oxford, England)|January 23, 2023
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosisNoemi Strahm, Henriette Didriksen, Håvard Fretheim, et al.
Scientific Reports|March 19, 2022
Serum markers of cardiac complications in a systemic sclerosis cohortAnders H Tennøe, Klaus Murbræch, Henriette Didriksen, et al.
Frontiers in Immunology|October 10, 2022
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertensionHenriette Didriksen, Øyvind Molberg, Adi Mehta, et al.
BMJ Open|June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trialAnna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
Plos One|May 22, 2020
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trialHåvard Fretheim, Brian K Chung, Henriette Didriksen, et al.
The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.
Pageof 1